aibio
Company Updates ·
Lifeloc reports second-quarter 2026 revenue up 10%
Net revenue rose to $2.445 million for the quarter ended June 30, 2026, and the company said it is targeting a limited commercial launch of SpinDetect in the first quarter of 2027.
LCTC Lifeloc Technologies, Inc
Lifeloc Technologies (LCTC) news
Latest Lifeloc Technologies news
- Company Updates
Lifeloc completes SpinDetect disk tooling and sets a staged rollout
Lifeloc completed production tooling for its SpinDetect test disks, commissioned a cleanroom, and expects a commercial launch in late 2026 or early 2027.
- Company Updates
Lifeloc reports first quarter 2026 results and SpinDetect milestone
Net revenue rose 1% to $2.294 million and the quarterly net loss narrowed. The company said production tooling for its SpinDetect drug analyzer is complete and first article disks have been delivered.
- Debt Financing
Lifeloc borrows $500,000 from its Chairman and CFO
Lifeloc Technologies entered into a $500,000 promissory note with Vern Kornelsen, its Chief Financial Officer and Chairman of the Board. The note carries 10.5% interest and is secured by its Wheat Ridge office and most of its assets.
Lifeloc Technologies annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $9.0 million | $8.5 million |
| Research and development | $2.2 million | $2.2 million |
| Net income (loss) | -$2.5 million | -$1.1 million |
| Cash from operations | -$499,319 | -$1.3 million |
| Cash and equivalents | $746,001 | $1.2 million |
Questions about Lifeloc Technologies
What is the ticker symbol of Lifeloc Technologies?
Lifeloc Technologies, Inc trades under the ticker LCTC on OTC.
Where is Lifeloc Technologies listed?
Lifeloc Technologies, Inc is listed on OTC.
Which country or territory is Lifeloc Technologies listed under?
Our directory records Lifeloc Technologies, Inc under United States.
Does aibio.space cover Lifeloc Technologies?
aibio.space lists Lifeloc Technologies, Inc among 2,820 public biotech companies and publishes its news here as stories appear.
What was Lifeloc Technologies's revenue last year?
$9.0 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.
Is Lifeloc Technologies profitable?
Lifeloc Technologies, Inc reported a net loss of $2.5 million for the fiscal year ended Dec 31, 2025, and used $499,319 of cash in operations, per its annual report to the SEC.
How much does Lifeloc Technologies spend on research and development?
$2.2 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does Lifeloc Technologies have?
$908,208 in cash at Jun 30, 2026, per its 10-Q.
What is the latest Lifeloc Technologies (LCTC) stock news?
Our latest story on Lifeloc Technologies, dated Aug 13, 2026: "Lifeloc reports second-quarter 2026 revenue up 10%". Net revenue rose to $2.445 million for the quarter ended June 30, 2026, and the company said it is targeting a limited commercial launch of SpinDetect in the first quarter of 2027. Source.
Does Lifeloc Technologies have debt, a term loan or convertible notes?
Our latest debt story, dated May 8, 2026: "Lifeloc borrows $500,000 from its Chairman and CFO". Lifeloc Technologies entered into a $500,000 promissory note with Vern Kornelsen, its Chief Financial Officer and Chairman of the Board. The note carries 10.5% interest and is secured by its Wheat Ridge office and most of its assets. Source.
How long will Lifeloc Technologies's cash last?
From our story of May 15, 2026: The release does not give a date for beta testing, and it does not state a cash runway figure. Source.
How can I follow Lifeloc Technologies (LCTC) news?
Press Follow on this page to add Lifeloc Technologies to your Following list, or subscribe to the aibio.space newsletter. We have published 4 stories naming Lifeloc Technologies so far, in Company Updates, Debt Financing.
Investor discussion: Lifeloc Technologies
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Legal
Reported a change of independent auditor. SEC Form 8-K (Items 4.01,5.07,9.01). Source
Stock chart
Listing details
- Company
- Lifeloc Technologies, Inc
- Ticker
- LCTC
- Listing
- OTC
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction